Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer
This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), March 2008
First Received: January 21, 2000   Last Updated: March 6, 2009   History of Changes
Sponsors and Collaborators: National Human Genome Research Institute (NHGRI)
National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00004210
  Purpose

RATIONALE: Identifying family and individual characteristics may help plan education and counseling for patients who are considering genetic testing.

PURPOSE: This clinical trial is studying education and counseling to see what effect they have in patients who are undergoing genetic testing for hereditary nonpolyposis colon cancer (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).


Condition Intervention
Colorectal Cancer
Genetic: loss of heterozygosity analysis
Genetic: microsatellite instability analysis
Genetic: mutation analysis
Other: counseling intervention

Genetics Home Reference related topics: Lynch syndrome
MedlinePlus related topics: Cancer Colorectal Cancer
U.S. FDA Resources
Study Type: Interventional
Official Title: Outcomes in Education and Counseling for HNPCC Testing

Further study details as provided by National Cancer Institute (NCI):

Estimated Enrollment: 900
Study Start Date: February 2000
Detailed Description:

OBJECTIVES:

  • Identify family characteristics, personality traits, and religious and spiritual beliefs that significantly affect individual decisions regarding mutation testing for hereditary nonpolyposis colon cancer (HNPCC) (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).
  • Determine the impact of negative vs positive mutation test results on family relationships and psychological status.
  • Assess expectations regarding testing and how they influence perceptions of risks and responses to risk notification.
  • Determine the impact of risk notification on the frequency of screening/prevention activities.
  • Formulate a standard diagnostic algorithm for determining microsatellite instability based on the analysis of tumors with this extensive array of markers and correlate specific replication error phenotypes with germline genotype.

OUTLINE: Participants complete a baseline assessment of knowledge, risk perception, and personality traits followed by a structured pretest education session. Participants are then offered the choice of whether or not to undergo genetic testing for mutations in hereditary nonpolyposis colon cancer (HNPCC) genes. Participants who choose to undergo genetic testing provide a blood sample for this purpose. Participants who undergo genetic testing receive results and counseling (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).

Available surveillance options are discussed for all participants. Psychological and behavioral outcomes are reassessed at 6 and 12 months for both those choosing and not choosing genetic testing.

Tumors (when available) are analyzed for mismatched repair deficiency on the basis of microsatellite instability.

PROJECTED ACCRUAL: A total of 900 participants will be accrued for this study, with a specific target of 200 individuals who have not experienced cancer within families identified with hereditary nonpolyposis colon cancer (HNPCC) mutations (recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues).

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Meets one of the following criteria:

    • Family history consistent with hereditary nonpolyposis colon cancer (HNPCC)*

      • At least 3 relatives with histologically proven colorectal cancer or HNPCC-associated cancer and 1 is a first-degree relative of the other 2
      • At least 2 successive generations affected
      • Colorectal cancer (or HNPCC-associated cancer) diagnosed under age 50 in 1 of the relatives
    • Diagnosis of colorectal cancer under age 41
    • HNPCC-associated cancer/polyps* under age 41 with a microsatellite instability (MSI) phenotype
    • Multiple primary HNPCC-associated cancers* regardless of family history
    • Colorectal or other HNPCC-associated tumor/polyp* demonstrating a positive MSI phenotype and at least 1 second-degree (or closer) and 1 third-degree (or closer) relative with a HNPCC-associated cancer

      • 1 affected family member must have one of the following:

        • Right-sided colon cancer
        • Multiple primary HNPCC-associated cancers
        • Diagnosis of cancer prior to age 51 NOTE: *Recruitment of new families with HNPCC stopped as of 04-26-06, recruitment of persons within families already participating continues

PATIENT CHARACTERISTICS:

Age:

  • 18 and over

Performance status:

  • Not specified

Life expectancy:

  • Not specified

Hematopoietic:

  • Not specified

Hepatic:

  • Not specified

Renal:

  • Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy:

  • Not specified

Chemotherapy:

  • Not specified

Endocrine:

  • Not specified

Radiotherapy:

  • Not specified

Surgery:

  • Not specified
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004210

Locations
United States, Maryland
National Human Genome Research Institute Recruiting
Bethesda, Maryland, United States, 20892-4470
Contact: Clinical Trials Office - National Human Genome Research Instit     301-402-8255        
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Recruiting
Bethesda, Maryland, United States, 20892-1182
Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center     888-NCI-1937        
Sponsors and Collaborators
Investigators
Study Chair: Donald W. Hadley, MS National Human Genome Research Institute (NHGRI)
  More Information

Additional Information:
Publications:
Study ID Numbers: CDR0000067459, NCI-95-HG-0165, NCI-NMOB-9501, NHGRI-95-HG-0165
Study First Received: January 21, 2000
Last Updated: March 6, 2009
ClinicalTrials.gov Identifier: NCT00004210     History of Changes
Health Authority: Unspecified

Keywords provided by National Cancer Institute (NCI):
colon cancer
rectal cancer

Study placed in the following topic categories:
Metabolic Diseases
Digestive System Neoplasms
Rectal Neoplasms
Gastrointestinal Diseases
Colonic Diseases
Rectal Neoplasm
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Rectal Cancer
Digestive System Diseases
Neoplastic Syndromes, Hereditary
Colorectal Neoplasms, Hereditary Nonpolyposis
Genetic Diseases, Inborn
Hereditary Nonpolyposis Colon Cancer
Gastrointestinal Neoplasms
Metabolic Disorder
Colorectal Neoplasms

Additional relevant MeSH terms:
Metabolic Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
DNA Repair-Deficiency Disorders
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Digestive System Diseases
Neoplastic Syndromes, Hereditary
Genetic Diseases, Inborn
Colorectal Neoplasms, Hereditary Nonpolyposis
Gastrointestinal Neoplasms
Colorectal Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009